BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22784592)

  • 1. [Improvements of ablative local treatments modify the management of the oligometastatic disease].
    Thariat J; Vignot S; Bensadoun RJ; Mornex F
    Cancer Radiother; 2012 Sep; 16(5-6):325-9. PubMed ID: 22784592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Stereotactic body radiation therapy and oligometastases].
    Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
    Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oligometastatic disease, a new concept: stereotactic irradiation for lung metastases. Literature review].
    Hatime M; Elmorabit B; Elkhoti Y; Touch S; Tanguy R; Mornex F
    Cancer Radiother; 2012 Sep; 16(5-6):351-7. PubMed ID: 22921980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating metastatic sarcomas locally: a paradoxe, a rationale, an evidence?
    Olivier T; Pop D; Chouiter Djebaili A; Falk AT; Iannessi A; Saada E; Nettekoven W; Blay JY; Baque P; Cupissol D; Thyss A; Thariat J
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):62-77. PubMed ID: 25630662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Strategies in Stereotactic Radiotherapy for Oligometastases.
    Palma DA; Louie AV; Rodrigues GB
    Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oligometastatic bone disease. Can limited metastatic bone disease be cured? Is there room for local ablative treatments?].
    Thariat J; Leysalle A; Vignot S; Marcy PY; Lacout A; Bera G; Lagrange JL; Clezardin P; Chiras J
    Cancer Radiother; 2012 Sep; 16(5-6):330-8. PubMed ID: 22921977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer.
    Shultz DB; Filippi AR; Thariat J; Mornex F; Loo BW; Ricardi U
    J Thorac Oncol; 2014 Oct; 9(10):1426-33. PubMed ID: 25170641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local ablative treatments of oligometastases from head and neck carcinomas.
    Florescu C; Thariat J
    Crit Rev Oncol Hematol; 2014 Jul; 91(1):47-63. PubMed ID: 24556572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local ablative stereotactic body radiotherapy for oligometastatic prostate cancer.
    Niazi T; Elakshar S; Stroian G
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):351-358. PubMed ID: 29979320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rationale for the targeted treatment of oligometastases with radiotherapy.
    Macdermed DM; Weichselbaum RR; Salama JK
    J Surg Oncol; 2008 Sep; 98(3):202-6. PubMed ID: 18618604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracranial oligometastatic renal cell carcinoma: current management and future directions.
    Loh J; Davis ID; Martin JM; Siva S
    Future Oncol; 2014 Apr; 10(5):761-74. PubMed ID: 24799057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management.
    Correa RJ; Salama JK; Milano MT; Palma DA
    Cancer J; 2016; 22(4):247-56. PubMed ID: 27441744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local ablative radiotherapy of oligometastatic colorectal cancer].
    Petersen C; Gauer T
    Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions.
    Inoue T; Katoh N; Aoyama H; Onimaru R; Taguchi H; Onodera S; Yamaguchi S; Shirato H
    Jpn J Clin Oncol; 2010 Aug; 40(8):788-94. PubMed ID: 20406944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Definitions of oligometastatic disease and new treatment concepts].
    Kissel M; Helou J; Thariat J
    Bull Cancer; 2018; 105(7-8):696-706. PubMed ID: 29935914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ knife radiosurgery of brain metastasis from breast cancer.
    Padovani L; Muracciole X; Régis J
    Prog Neurol Surg; 2012; 25():156-62. PubMed ID: 22236677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oligometastatic state - separating truth from wishful thinking.
    Palma DA; Salama JK; Lo SS; Senan S; Treasure T; Govindan R; Weichselbaum R
    Nat Rev Clin Oncol; 2014 Sep; 11(9):549-57. PubMed ID: 24958182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.